5Pierre C, Roland R, Tremblay P. Nitrophenol-αglucopyramoside as substrate for measurement of maltase activity in human semen. The Journal of Clinical Chemistry, 1978,24: 208～ 211
6Ye F,Shen Z, Xie M. Alpha-glucosidase inhibition from a Chinese medical herb (Ramulus mori ) in normal and diabetic rats and mice. Phytomedicine,2002,9(2): 161 ～166
7Matsuo T, Odaka H, Ikeda H. Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes.Am J Clin Nutr, 1992, 55 ( 1 Suppl): 314S～ 317S
8 Scheen AJ. Drugtreatment of NIDDM in the 1990s[J].Drugs, 1997,54(3)∶355
9 Mooradian AD, Thurman JE. Drug therapy of postprandial hyperglycaemia[J].Drugs,1999,57(1)∶19 [3] Langtry HD, Balfour JA. Glimepiride: A review of its use in the management oftype 2 diabetes mellitus[J].Drugs, 1998,55(4)∶563
10 Graul A, Castaner J. Repaglinide[J].Drugs Future,1996,21(7)∶694
9Ye Tian,Yue Jiang,Shiyi Ou.Interaction of cellulase with three phenolic acids[J].Food Chemistry (-).2013(2-3)
10Imen Boukari,Michael O’Donohue,Caroline Rémond,Brigitte Chabbert.Probing a family GH11 endo-β-1,4-xylanase inhibition mechanism by phenolic compounds: Role of functional phenolic groups[J].Journal of Molecular Catalysis B Enzymatic.2011(3)
